Dupixent would be the first and only medicine specifically indicated to treat prurigo nodularis in the U.S., if approved
This agreement is in addition to the $92 million filling line expansion announced in November 2021
OS-SiA is the industry’s first AI-enabled digital scanner that will provide real-time predictive analysis and actionable insights
The ABDM public dashboard is a one-stop solution for information on the mission’s progress up to state/UT level
Already an existing partner and supplier of ingredients to Medisca, striking this agreement with SUANFARMA involved reinforcing a well-established symbiotic relationship between two companies committed to world-class quality, service, and price
The company’s annual sales grew from Rs 548.12 crore in FY 2020-21 to Rs 598.65 crore this fiscal
RSV is the most common viral cause of respiratory tract infections in newborns, young children, older adults, or the immunocompromised
Data from the three studies formed the basis of the company's application for approval by regulatory agencies
Manamed, a pioneering Medical Technology development company, has been granted FDA approval on its latest orthopaedic recovery device, ManaSport.
The acquisition is subject to customary closing conditions and necessary regulatory approvals. The financial terms of the transaction are confidential
Subscribe To Our Newsletter & Stay Updated
